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Organisms must be able to respond to low oxygen in
a number of homeostatic and pathological contexts.
Regulation of hypoxic responses via the hypoxia-
inducible factor (HIF) is well established, but evi-
dence indicates that other, HIF-independent mecha-
nisms are also involved. Here, we report a hypoxic
response that depends on the accumulation of
lactate, a metabolite whose production increases in
hypoxic conditions. We find that the NDRG3 protein
is degraded in a PHD2/VHL-dependent manner in
normoxia but is protected from destruction by bind-
ing to lactate that accumulates under hypoxia. The
stabilized NDRG3 protein binds c-Raf to mediate
hypoxia-induced activation of Raf-ERK pathway,
promoting angiogenesis and cell growth. Inhibiting
cellular lactate production abolishes the NDRG3-
mediated hypoxia responses. Our study, therefore,
elucidates the molecular basis for lactate-induced
hypoxia signaling, which can be exploited for the
development of therapies targeting hypoxia-induced
diseases.
INTRODUCTION
Oxygen homeostasis is essential for metazoan physiology.
Under low oxygen conditions, cells resort to hypoxia-induced
responses to adapt to and survive harsh environments (Cassa-
vaugh and Lounsbury, 2011). Hypoxia responses are an integral
part of normal physiology during embryonic development and
postnatal life. They are also pathophysiologic components of
many disorders, including cancer, inflammation, and cardiovas-
cular diseases.
Hypoxia inducible factors (HIFs) play central roles in hypoxia
responses by controlling the expression of a host of hypoxia-
responsive genes functioning in diverse processes, including
metabolism, oxygen delivery, pH regulation, angiogenesis, cell
proliferation, and survival (Harris, 2002; Cassavaugh and Louns-bury, 2011). In particular, the HIF-mediated upregulation of
glycolysis and suppression of the citric acid (TCA) cycle is a
crucial adaptive response at the early stage of hypoxia (Cassa-
vaugh and Lounsbury, 2011). The expression and activity of
HIFs are tightly regulated by oxygen-dependent hydroxylation
of their a subunits (Semenza, 2003).
Growing evidence indicates that hypoxia has many aspects
that are not explained by HIF-mediated mechanisms alone. For
example, the inhibition of HIF-mediated pathways does not al-
ways prevent tumor growth; tumors derived from HIF-1a-defi-
cient embryonic stem (ES) cells have growth advantages owing
to decreased hypoxia-induced apoptosis and increased stress-
induced proliferation (Carmeliet et al., 1998). A number of reports
suggest that tumor angiogenesis constitutes the major pathway
of HIF-independent tumorigenesis. Thus, angiogenesis was
preserved when HIF1A was knocked-out in ES cells (Ho¨pfl
et al., 2002). Several lines of evidence indicate that the pro-
angiogenic factor, vascular endothelial growth factor (VEGF),
can be induced via both HIF-dependent and HIF-independent
pathways (Mizukami et al., 2004). Induction of other pro-angio-
genic factors such as IL-8 preserves the angiogenic response
in HIF-1a-deficient colon cancer cells (Mizukami et al., 2005).
Moreover, multiple pathways and transcription factors (TFs)
other than HIFs are known to respond to hypoxia to induce bio-
logical responses in a HIF-independent manner. Among those
oxygen-regulatable TFs are NF-kB, AP-1, and CEBP, which
are activated in hypoxia (Cummins and Taylor, 2005). Conse-
quently, several reports demonstrated that some of the genes
regulated by hypoxia were not regulated by HIFs, suggesting a
role for other oxygen-regulated pathways that are, similar to
HIF pathways, controlled by prolyl hydroxylase domain (PHD)
enzymes (Elvidge et al., 2006). Also, a number of protein kinases
such as PKA, PKC, PI3K, AKT, JNK, PTK2B (Pyk2), SRC,
MAPK14 (p38), and ERK1/2 are reported to be activated in hyp-
oxia (Seta et al., 2002). However, despite all of these studies, key
elements and mechanisms responsible for oxygen-dependent
regulation of the HIF-independent branch of hypoxia responses
remain elusive.
In this study, we identified an oxygen-regulated protein,
NDRG3 (NDRG family member 3; NM_032013), as a bona fide
substrate of the PHD2/VHL system. NDRG3 was highly inducedCell 161, 595–609, April 23, 2015 ª2015 Elsevier Inc. 595
under oxygen-limited conditions in diverse cell types, although
its mRNA expression was independent of HIF levels under hyp-
oxia. Interestingly, NDRG3 required binding by the glycolytic
end-product lactate for its hypoxic accumulation, rendering its
expression indirectly dependent on HIF expression as HIF-1a
regulates the hypoxic expression of lactate dehydrogenase A
(LDHA). We found that NDRG3 plays critical roles in lactate-
induced hypoxia signaling by mediating the activation of the
Raf-ERK pathway to promote angiogenesis and cell growth dur-
ing prolonged hypoxia. Thus, NDRG3 provides a critical genetic
element for the oxygen- and lactate-dependent regulation of
prolonged hypoxia responses.
RESULTS
Identification of NDRG3 as the Substrate of PHD2
To identify the regulators of hypoxia responses, we searched for
PHD2-binding proteins in MCF-7 cells expressing Flag-tagged
PHD2 via Flag-mediated immunoprecipitation coupled to mass
spectrometry. Among the candidates enriched in the protein
bands reproducibly exhibiting differential immunoprecipitation
patterns between mock and PHD2-Flag fractions, we chose
NDRG3 for further studies since it belongs to a gene family impli-
cated in cell proliferation, migration, and invasion as well as in
differentiation and development (Melotte et al., 2010), which
are biological features closely associated with hypoxia (Harris,
2002; Cassavaugh and Lounsbury, 2011) (Figure S1A).
To characterize NDRG3 in detail, we developed an affinity-pu-
rified polyclonal antibody specific to NDRG3 among the human
NDRG family members (Figure S1B). This antibody detected
NDRG3 as a 42-KDa band in the PHD2-Flag immunoprecipita-
tion fraction (Figure 1A). We verified the NDRG3-PHD2 interac-
tion by immunoprecipitating endogenous NDRG3 with PHD2-
Flag from HeLa cells grown under hypoxia (Figure 1B) and
directly by a pull-down assay using recombinant PHD2-His
and NDRG3-GST proteins (Figure S1C). Thus, we concluded
that NDRG3 is a bona fide PHD2-binding protein.
We then examined possible functional relationships between
PHD2 and NDRG3 using a PHD inhibitor, desferrioxamine
(DFX). Although the basal-level expression of NDRG3 was negli-
gible, PHD inhibition caused its dose-dependent accumulation
in HeLa (Figure 1C) and MCF-7 cells (Figure S1D). These results
were reproducible with two other PHD inhibitors, dimethyloxa-
loylglycine (DMOG) and CoCl2 (Figure S1E), suggesting that
the NDRG3 protein expression might be under PHD-mediated
posttranslational control. We then examined different PHD family
members for their involvement in the regulation of NDRG3 by
silencing their expression under normoxia using small interfering
RNAs (siRNAs). The analysis results revealed that, as in the case
of HIF-1a, PHD2 is the major regulator of NDRG3 expression
among the PHD family members (Figure 1D, left). This was sup-
ported by the identification of differential interactions between
NDRG3 and PHD2 in a co-immunoprecipitation assay (Fig-
ure S1F). Depletion of VHL, the targeting element of E3 ubiquitin
ligase complex, also caused NDRG3 accumulation under nor-
moxia (Figure 1D, right), suggesting that NDRG3 is likely a
target of PHD2/VHL-mediated posttranslational modification.
To address this point more thoroughly, we prepared several var-596 Cell 161, 595–609, April 23, 2015 ª2015 Elsevier Inc.iants of the NDRG3 protein carrying single amino acid changes in
their putative PHD2-docking site, predicted from a docking
model between a putative NDRG3 structure and the published
PHD2 structure (Chowdhury et al., 2009) (Figure S1G). A co-
immunoprecipitation assay showed that the NDRG3 mutants
could be ranked according to their PHD2-binding strengths in
the following order: V296D > Q97E > R47D z N66D, which,
interestingly, appeared to be inversely correlated with their pro-
tein expression levels in normoxia (Figure 1E). Moreover, NDRG3
variants retaining higher affinity for PHD2 co-immunoprecipi-
tated higher amount of HA-tagged VHL protein (Figure 1E),
indicating that the interaction of NDRG3 with PHD2 and VHL
is a critical determinant of its protein expression. Next, in an
in vivo ubiquitination assay, the amount of ubiquitin immunopre-
cipitated with NDRG3 was increased by overexpression of
NDRG3, while it was decreased by silencing of its expression
by different short hairpin RNAs (shRNAs) (Figures 1F and S1H).
In addition, proteasome inhibition with MG132 dramatically
increased the detected levels of NDRG3 in HeLa cells (Fig-
ure S1I). Collectively, these results demonstrate that NDRG3 is
a PHD2-interacting protein whose expression is negatively regu-
lated by PHD2/VHL-mediated proteasomal pathways.
Oxygen-Dependent Regulation of NDRG3 Protein
Expression
Since PHD2 critically depends on O2 availability for its activity,
we examined whether the NDRG3 protein expression is regu-
lated in an oxygen-dependent manner. NDRG3 accumulated in
MCF-7 cells at rates that were inversely correlated with O2 con-
centrations (Figures 2A and S2A). Consistent with this, NDRG3
ubiquitination was significantly suppressed in HeLa cells under
hypoxia (Figure 2B). The hypoxic induction of NDRG3 was
demonstrated in cancer cells of diverse tissue origins as well
as in non-transformed cells (Figure S2B), suggesting a universal-
ity of the phenomenon. However, in contrast to HIF-1a protein
showing a sort of bell-shaped induction pattern at the early stage
of hypoxia, NDRG3 exhibited a sigmoidal expression pattern,
starting when HIF-1a levels began to decline and lasting until
later stages of hypoxia (Figure 2C). The hypoxic expression of
NDRG3 slowly diminished as cells were reoxygenated (Fig-
ure S2C). These results strongly suggest that NDRG3 protein
expression is negatively regulated by oxygen.
Next, we investigated the molecular basis of the oxygen-
dependent regulation of NDRG3 protein expression. Mass
spectrometric analysis revealed that NDRG3 is specifically hy-
droxylated at proline 294, suggesting that it might be the residue
modified by PHD2 (Figure 2D). Site-directedmutagenesis of pro-
line 294 to alanine (P294A) resulted in pronounced accumulation
of the variant protein in normoxia (Figure 2E, left). Moreover, a
co-immunoprecipitation assay showed that the P294A mutant
protein possessed a significantly reduced binding affinity for
PHD2 and VHL proteins compared to wild-type (Figure 2E, right),
indicating that proline 294 is the critical target site of PHD2-
mediated hydroxylation that determines NDRG3 protein stability
in normoxia.
Since the expression of HIF-1a immediately preceded that of
NDRG3 (Figure 2C), we investigated the possibility of HIF-1a
transcriptionally regulating NDRG3 expression during hypoxia.
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Figure 1. NDRG3 Protein Is Regulated by PHD2/VHL-Mediated Proteasomal Pathway
(A) Identification of NDRG3 as a PHD2-binding protein in MCF-7 cells.
(B) Validation of PHD2-NDRG3 interaction in HeLa cells under hypoxia.
(C) Induction of NDRG3 protein by inhibiting PHDs with desferrioxamine (DFX) in HeLa cells at normoxia. Results are mean ± SD of three experiments.
(D) Effects of depleting different PHD family members (left) or VHL (right) on NDRG3 protein expression in HeLa cells in normoxia.
(E) Expression pattern of NDRG3 variants mutated in putative PHD2-binding sites and their interaction with PHD2 and VHL in HEK293T cells.
(F) Ubiquitination assay of NDRG3 protein in HeLa cells at normoxia.
See also Figure S1.RT-PCR analysis showed that NDRG3 mRNA level remained
virtually unchanged during hypoxia, even when HIF proteins
reached their peak levels (Figure S2D). This result indicates the
HIF independence of NDRG3 transcription and confirms the
posttranslational nature of NDRG3 expression during hypoxia.
Depletion of different subunits of HIF had no effects on NDRG3
mRNA levels, confirming the HIF independence of its transcrip-
tion (Figure 2F). It is noteworthy that although NDRG3 protein
expression in hypoxia was clearly detectable in HIF-silenced
cells, it was significantly reduced compared to control by HIF-
1b knockdown and, to a much lesser extent, by HIF-1a knock-down, suggesting a potential non-transcriptional effect of the
HIF pathway on NDRG3 protein expression. Meanwhile, we
could show that HIF played a role as a transcriptional activator
for the hypoxic expression of another NDRG family member,
NDRG1 (Figure S2E). These results collectively indicate that
HIF activity is not required for the transcriptional regulation of
NDRG3 expression during hypoxia.
Role of NDRG3 in the Regulation of Hypoxia Responses
We investigated the potential functions of NDRG3 in hypoxia
by correlating its protein expression profile with the genomicCell 161, 595–609, April 23, 2015 ª2015 Elsevier Inc. 597
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Figure 2. NDRG3 Expression Is Regulated in an Oxygen-Dependent Manner
(A) NDRG3 protein expression at different oxygen concentrations in MCF-7 cells. Quantified values for western blot images are shown on the right. Results are
mean ± SD of three experiments.
(B) Oxygen dependency of NDRG3 protein ubiquitination in vivo.
(C) NDRG3 protein expression inMCF-7 cells during prolonged hypoxia. Quantified values for western blot images are shown on the right. Results are mean ± SD
of three experiments.
(D) Site of prolyl hydroxylation in NDRG3 identified by micro-LC-MS/MS analysis.
(E) Expression pattern of an NDRG3 variant mutated in putative prolyl hydroxylation site (P294A) (left) and its interaction with PHD2 and VHL proteins (right) in
HEK293T cells. WT, wild-type.
(F) Effects of silencing HIF proteins on hypoxic expression of NDRG3 in Huh-1 cells.
See also Figure S2.
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activity profile of five gene ontology categories representative of
hypoxia responses (Figure S3A). The genomic activity of a gene
ontology was estimated via the gene set enrichment analysis,
whereby a standardized difference score (Z score) was calcu-
lated from transcriptome expression data of Huh-7 cells at a
particular time point during hypoxia. The results showed that
NDRG3protein expression was highly correlatedwith the activity
of ‘‘angiogenesis,’’ ‘‘anti-apoptosis,’’ ‘‘proliferation (positive),’’
and ‘‘motility’’ functions but not with ‘‘glycolysis’’ (Figure 3A).
On the other hand, depletion of NDRG3 at 24 hr under hypoxia,
when cellular NDRG3 protein expression should have otherwise
reached a significant level, caused significant changes in
the activity of ‘‘angiogenesis,’’ ‘‘anti-apoptosis,’’ ‘‘proliferation
(positive),’’ and ‘‘motility’’ categories but not that of ‘‘glycolysis’’
(Figure 3B). In contrast, ‘‘glycolysis’’ was significantly targeted
by HIF-1a depletion at 6 hr under hypoxia, when HIF-1a
protein expression is expected to have reached its peak level
(Figure S3B). Consistently, the ectopic expression of a nor-
moxia-stable variant of NDRG3 (N66D in Figure 1E) caused
the upregulation (>1.5-fold) of genes having primary functions
in angiogenesis > proliferationz growthz apoptosiszmigra-
tion > glycolysis (Figure S3C).
We then experimentally evaluated the roles of NDRG3 in
‘‘angiogenesis,’’ ‘‘anti-apoptosis,’’ and ‘‘proliferation,’’ the func-
tions often implicated in tumor growth and significantly targeted
by NDRG3 depletion (Figure 3B). In tube forming assays using
HUVEC cells, NDRG3 depletion caused significant suppression
of the angiogenic activity induced by hypoxia in Huh-7 cells
(Figure S3D). In parallel, the Matrigel plug assay showed that
NDRG3 knockdown inhibited the angiogenic activity of Huh-7
cells in BALB/c-nu mice (Figure 3C). At the molecular level,
hypoxia-induced expression of pro-angiogenic markers was
abolished by NDRG3 depletion, while it was upregulated in nor-
moxia by NDRG3(N66D) (Figure 3D). Next, examination of the
anti-apoptotic activity of NDRG3 via caspase-3/7 and PARP
cleavage assays indicated that NDRG3 depletion significantly
promotes apoptosis in hypoxia (Figure 3E). Accordingly, the hyp-
oxia-induced expression of anti-apoptotic genes, notably mem-
bers of the IAP (inhibitor of apoptosis proteins) family, was abol-
ished by NDRG3 depletion in Huh-7 cells (Figure 3F). Moreover,
the depletion of NDRG3 using an shRNA targeting its 30-UTR
(Figure S1H, #5) significantly inhibited the growth of Huh-7 cells
under mild hypoxia (3% O2; Figure 3G), but this phenotype was
effectively rescued by a recombinant NDRG3(N66D) expression
vector lacking the natural 30-UTR sequences of NDRG3 (Figures
3G and S3E). In addition, NDRG3 knockdown strongly sup-
pressed the tumorous growth of Huh-7 cells in BALB/c-nu
mice (Figures 3H and S3F). Interestingly, simultaneous depletion
of NDRG3 and either of the HIFs completely abrogated tumor
growth, suggesting complementary roles for NDRG3 and HIFs
in hypoxic cell growth (Figure 3H). Immunofluorescence micro-
scopy of resected tumors revealed that NDRG3 depletion
effectively suppressed the expression of markers of tumor
angiogenesis (IL8 and CD31) and cell proliferation (Ki-67), while
their levels in HIF-depleted tumors were comparable to those
in controls (Figure S3G). In contrast, the ectopic expression of
NDRG3(N66D) highly promoted colony formation of Huh-1 cells
in soft agar (Figure S4J) as well as their tumorigenic activity inBALB/c-nu mice (Figures 3I and S3H). These results demon-
strate that NDRG3 plays crucial roles in promoting angiogenesis,
anti-apoptosis, and cell proliferation during hypoxia.
L-Lactate Triggers the NDRG3-Mediated Hypoxia
Responses
Compared to HIF-1a, which showed an early induction pattern
during hypoxia and rapidly disappeared upon reoxygenation of
cells, NDRG3 started accumulating relatively later in hypoxia
and its levels slowly declined upon reoxygenation (Figures 2C
and S2C). The long lag periods observed for the accumulation
and degradation of NDRG3 suggested that multiple layers of
regulationmight be involved in its hypoxic expression. Therefore,
we explored biochemical features relevant to ‘‘prolonged hypox-
ia’’ other than low oxygen levels and found that NDRG3 protein
expression is highly correlated with cellular lactate production;
NDRG3 protein expression began at 6 hr under hypoxia,
closely following the lactate production pattern (Figure 4A). On
the other hand, suppression of lactate production with a LDHA
inhibitor, sodium oxamate, specifically inhibited the NDRG3
protein accumulation in a dose-dependent manner (Figure 4B).
Similarly, inhibition of lactate production via siRNA-mediated
depletion of LDHA (Figure 4C) or disruption of glycolysis with
2-deoxyglucose (Figure S4A) suppressed the hypoxic NDRG3
protein expression. Depriving cells of glucose and/or glutamine,
the input substrates for glycolysis and glutaminolysis, respec-
tively—two major metabolic pathways leading to intracellular
lactate production—also reduced the NDRG3 protein accumula-
tion with a parallel reduction in lactate production but without
affecting the transcription of NDRG3 (Figure 4D). However,
compared to the significant consequences of glucose depriva-
tion, the glutamine effect seemed relatively minor. In contrast,
the facilitation of lactate production (via LDHA overexpression
and/or pyruvate overfeeding; Figure S4B) or its intracellular
accumulation (by blocking export through MCT4; Figure 4C)
augmented the hypoxic accumulation of NDRG3 protein. These
results indicate that, unlike HIF proteins, oxygen deprivation per
se is not enough to cause the accumulation of NDRG3 protein,
but glycolytic production of lactate is additionally required.
We then verified the effects of lactate on NDRG3 protein dy-
namics more directly by providing exogenous lactate to the cells
whose intracellular lactate production had been compromised
by genetic or pharmacological means. Lactate exogenously
added to Huh-1 cells dose dependently restored the hypoxic
NDRG3 protein expression that had been reduced by LDHA
silencing, without affecting the level of NDRG3 mRNA or HIF-
1a protein (Figure 4E). Similar results were obtainedwhen lactate
production was suppressed by glucose deprivation (Figure S4C)
or oxamate treatment (Figure S4D). However, the lactate-medi-
ated restoration of NDRG3 protein expression was abrogated
by siRNA targeting MCT1, a monocarboxylate transporter res-
ponsible for importing extracellular lactate into the cell, both in
normoxic and hypoxic conditions (Figure 4F). We also observed
similar effects of MCT1 knockdown in Huh-1 cells subjected to
oxamate treatment or glucose deprivation (Figures S4E and
S4F). Collectively, these results indicate that NDRG3 requires
lactate build-up for its protein accumulation under hypoxia,
pointing to the possibility that NDRG3 might function as aCell 161, 595–609, April 23, 2015 ª2015 Elsevier Inc. 599
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Figure 3. NDRG3 Is a Critical Regulator of Prolonged Hypoxia Responses
(A) Correlation analyses between the NDRG3 protein expression during hypoxia and the activity of five representative hypoxia-responsive gene sets.
(B) Changes in the activity of hypoxia-responsive gene sets upon NDRG3 silencing in Huh-7 cells at 24 hr under hypoxia (1% O2).
(C) Matrigel plug assay of NDRG3-mediated angiogenic activity. The p value was assessed by Student’s t test.
(D) Regulation of pro-angiogenic gene expression by NDRG3. Gene expression in NDRG3-silenced Huh-7 cells under hypoxia (1% oxygen, left) or in
NDRG3(N66D)-overexpressing HeLa cells at normoxia (right) was examined by RT-PCR.
(E) Effects of NDRG3 knockdown on hypoxia-induced apoptosis in Huh-7 cells. Results are mean ± SD of three experiments. The p value was assessed by
Student’s t test.
(F) Regulation of hypoxia-induced anti-apoptotic gene expression by NDRG3.
(legend continued on next page)
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hypoxia-inducible lactate sensor, triggering HIF-independent
biologic responses in the cell.
We, therefore, examined the functional significance of hypoxic
NDRG3 expression in the context of lactate metabolism. Inhibi-
tion of lactate production with oxamate caused a dose-depen-
dent suppression of Huh-1 cell growth under mild hypoxia
(Figure S4G). However, this effect was effectively rescued by
ectopically expressing NDRG3(N66D) (Figure S4G), suggesting
that NDRG3 may play a critical role in lactate-induced hypoxic
cell growth. Apparently, NDRG3(N66D) exerted no direct
effects on lactate production irrespective of oxamate treatment
(Figure S4H) nor was its expression affected by oxamate (Fig-
ure S4I), indicating that the rescuing effect is truly inherent in
NDRG3(N66D) itself. The effect of oxamate on cell growth and
its rescue by NDRG3(N66D) were further corroborated by colony
forming assays using Huh-1 cells (Figure S4J). We then exam-
ined the role of NDRG3 in the growth of cells whose LDHA
expression was ablated by RNAi. Depletion of LDHA by shRNA
suppressed the growth of Huh-1 cells under mild hypoxia (Fig-
ure S4K) as well as their tumorous growth in BALB/c-nu mice
(Figures 4G and S4L). Again, NDRG3(N66D) effectively compen-
sated for the LDHA deficit both in vitro and in vivo. Moreover, in
tube forming assays using HUVEC cells, oxamate suppressed
the angiogenic activity induced in Huh-1 cells under hypoxia
(Figure 4H). However, the ectopic expression of NDRG3(N66D)
restored the angiogenic activity in these cells in spite of the
oxamate treatment. Thus, lactate appears to be a crucial
signal for hypoxic cell growth and angiogenesis, and NDRG3
functions as a key mediator of the lactate-induced hypoxia
responses.
Molecular Mechanism of the Lactate Regulation of
NDRG3 Protein Expression
We investigated the molecular mechanism for the lactate-in-
duced NDRG3 protein accumulation by examining the effect of
lactate on the ubiquitination of NDRG3. In vitro, lactate inhibited
NDRG3 ubiquitination, catalyzed by the PHD2/VHL complex
immunoprecipitated from HEK293T cells (Figure 5A), indicating
that lactate can block the modification of NDRG3 protein by
PHD2/VHL. It seems clear that lactate does not affect the HIF-
1a protein expression under hypoxia (Figures 4 and S4). We,
therefore, examined the possibility of lactate directly modulating
NDRG3by investigating interactions between the twomolecules.
An in vitro binding experiment using GST-tagged recombinant
NDRG3 protein and [14C]-labeled L-lactate indicated that
NDRG3 physically and directly binds lactate (Figures 5B and
S5B). To verify the NDRG3-lactate interaction further, we pre-
dicted the putative lactate-binding domain of NDRG3 by a
docking simulation (not shown). Site-directed mutagenesis of
the predicted lactate-binding domain showed that mutations in
some of its amino acid residues can impair the hypoxic accumu-
lation of the mutant proteins (Figure S5A). One of the variants(G) Inhibition of hypoxic cell growth by NDRG3 knockdown and its rescue by NDR
value was assessed by Student’s t test.
(H) Effects of the knockdown of NDRG3 and/or HIF-a on the tumorigenic activity
(I) Tumorigenic activity of Huh-1 cells overexpressing NDRG3(N66D). The p valu
See also Figure S3.whose glycine-138 was mutated to tryptophan (N3(G138W) in
Figure S5A) hardly accumulated under hypoxia, but accumulated
in the presence of MG132, suggesting that it may have lost the
lactate-binding capability necessary for escaping PHD2/VHL-
mediated proteasomal degradation. Indeed, we observed that
recombinant N3(G138W)-GST protein has a severely impaired
lactate-binding capability in an in vitro binding assay (Figures
5C and S5B). These results suggest that binding by lactate
inhibits proteasomal degradation ofNDRG3byblocking itsmodi-
fication by PHD2/VHL. Moreover, once formed, the NDRG3-
lactate complex seems to remain quite resistant to the PHD2/
VHL-mediated modification since the hypoxically accumulated
NDRG3 protein was maintained for a while after culturing the
cells in fresh medium under normoxia (Figure S2C). In contrast,
HIF-1a rapidly disappeared upon reoxygenation, demonstrating
the exquisite oxygen dependency of its post-translational
regulation.
We further investigated the mechanisms behind the lactate-
induced changes in NDRG3 protein dynamics through protein
binding analyses in HEK293T cells expressing epitope-tagged
NDRG3, PHD2, and VHL. Binding between NDRG3 and PHD2
during early (6 hr) or late (24 hr) hypoxia did not significantly differ
from that in normoxia, suggesting that neither low oxygen nor
high lactate levels affects the NDRG3-PHD2 interaction (Fig-
ure 5D). By contrast, binding between NDRG3 and VHL was
significantly reduced at 24 hr under hypoxia, while it was main-
tained at normoxic levels at 6 hr under hypoxia, indicating that
high lactate levels but not low oxygen levels might affect the
NDRG3-VHL interaction. We then verified these observations
using NDRG3 variants having defects in prolyl hydroxylation by
PHD2 (P294A) or lactate binding (G138W). None of the wild-
type or variant NDRG3 species showed significant differences
in their PHD2-binding capacity between normoxia and hypoxia
(24 hr) (Figure 5E). On the other hand, the VHL-binding capacity
of wild-type NDRG3 was significantly reduced under hypoxia
compared to that in normoxia, while those of P294A and
G138W were barely changed by hypoxia. Notably, the interac-
tion of P294A with VHL was negligible whereas the G138W-
VHL interaction was strongly maintained, regardless of oxygen
level. Consistently, ubiquitination of wild-type NDRG3 was
significantly reduced under hypoxia, while P294A and G138W
were negligibly and strongly ubiquitinated, respectively, in both
normoxia and hypoxia (Figure 5F). Conversely, oxamate treat-
ment specifically augmented the hypoxic interaction of wild-
type NDRG3 with VHL as well as its ubiquitination (Figures 5G
and S5C). Inhibition of hypoxic lactate production by glucose
deprivation also resulted in the augmentation of the NDRG3-
VHL interaction (Figure S5D). Addition of exogenous lactate to
oxamate-treated cells specifically inhibited the NDRG3-VHL
interaction in both normoxia and hypoxia (Figure S5E). Thus,
we conclude that the NDRG3-PHD2 interaction is not affected
by cellular oxygen or lactate levels, while the NDRG3-VHLG3(N66D) overexpression. Results are mean ± SD of three experiments. The p
of Huh-7 cells in vivo. The p value was assessed by Student’s t test.
e was assessed by Student’s t test.
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Figure 4. Lactate Signals for the NDRG3-Mediated Hypoxia Responses
(A) Intracellular NDRG3 protein accumulation and gross lactate production by MCF-7 cells during hypoxia. N, normoxia. Results are mean ± SD of three ex-
periments. The p value was assessed by Student’s t test.
(B) Effects of the pharmacological inhibition of lactate dehydrogenase on hypoxic lactate production and NDRG3 protein expression by MCF-7 cells. Results are
mean ± SD of three experiments. The p value was assessed by Student’s t test.
(C) Effects of depleting the genes of lactate metabolism on the hypoxic expression of NDRG3 protein and intracellular lactate levels in HeLa cells. Results are
mean ± SD of three experiments. The p value was assessed by Student’s t test.
(D) Hypoxic expression of NDRG3 and lactate production in Huh-1 cells deprived of glucose (Glc) or glutamine (Gln). Results are mean ± SD of three experiments.
The p values were assessed by Student’s t test.
(E) Effects of exogenous lactate on the hypoxic expression of NDRG3 in LDHA-silenced Huh-1 cells.
(F) Effects of MCT1 depletion on the NDRG3 protein expression induced by exogenous lactate in LDHA-silenced Huh-1 cells.
(legend continued on next page)
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interaction is significantly inhibited by lactate but not by low ox-
ygen levels.
In summary, excess lactate built up during hypoxia directly
binds to NDRG3 and inhibits its ubiquitination and proteasomal
degradation by disrupting the NDRG3-VHL interaction. How-
ever, the question remains whether failure of NDRG3 ubiq-
uitination in high lactate conditions is due to the inhibition of
PHD2-mediated hydroxylation of NDRG3 that is required for
VHL binding and awaits further studies.
Activation of Raf-ERK Signaling by NDRG3 during
Hypoxia
To understand the molecular mechanisms of NDRG30s function
in hypoxia, we searched for possible NDRG3-regulated kinases
via a phosphoarray analysis using PLC/PRF/5 cells stably ex-
pressing shRNA for NDRG3 or GFP (Figure S6A). NDRG3 deple-
tion selectively suppressed hypoxia-induced ERK1/2 phosphor-
ylation (Figures 6A and S6A). We then examined whether the
kinases upstream of ERK1/2 could be regulated by NDRG3
and found that hypoxia-induced phosphorylation of c-Raf (at
Ser338) and B-RAF1 (at Ser445) is abrogated by NDRG3 deple-
tion in SK-Hep-1 cells (Figure 6B). These results suggest that
NDRG3 might play an essential role in the activation of the
RAF-ERK signaling pathway. We, therefore, examined the effect
of manipulating NDRG3 expression on c-Raf phosphorylation
and found that ectopically expressed c-Raf was significantly
phosphorylated in normoxia, with a concomitant phosphoryla-
tion of ERK1/2 (Figure 6C). However, depletion of basal-level
NDRG3 expression by siRNA abrogated this response. On the
other hand, the ectopic expression of NDRG3(N66D) highly
induced the phosphorylation of c-Raf and ERK1/2 (Figure 6C).
Also, the hypoxia-induced phosphorylation of endogenous c-
Raf and ERK1/2, which was suppressed by the 30-UTR-targeting
shRNA of NDRG3, could be rescued by the recombinant
NDRG3(N66D) expression vector (Figure 6D). Reciprocal
in vitro pull-down assays indicated that NDRG3 can physically
and directly interact with c-Raf (Figure S6B). Consistently,
ectopically expressed c-Raf immunoprecipitated endogenous
NDRG3 protein specifically under hypoxia (Figure S6C). More-
over, an NDRG3(N66D)-containing complex immunoprecipi-
tated from HEK293T cells mediated the phosphorylation of
recombinant c-Raf in an in vitro kinase assay (Figure 6E). These
results indicate that NDRG3 is directly involved in the phosphor-
ylation of c-Raf.
We then examined the biological implications of the NDRG3-
mediated c-Raf-ERK1/2 phosphorylation. We observed, from
the immunoprecipitation analysis of endogenous proteins, in-
creasing amounts of c-Raf-NDRG3 complexes during the pro-
gression of hypoxia, in parallel with a temporal increase in the
phosphorylation levels of c-Raf and ERK1/2 (Figure 6F). This
result suggests a potential role of NDRG3-mediated c-Raf-
ERK1/2 phosphorylation in hypoxia response regulation. Abla-
tion of LDHA to inhibit lactate production effectively suppressed(G) Dependence of the tumorous growth of Huh-1 cells on LDHA and its rescue
(H) Inhibition of hypoxia-induced angiogenesis by oxamate and its rescue byNDR
Student’s t test. Scale bar, 200 mm.
See also Figure S4.the hypoxia-induced phosphorylation of c-Raf and ERK1/2 as
well as NDRG3 protein expression (Figure 6G). Exogenously pro-
vided lactate rescued the siLDHA-mediated suppression of c-
Raf and ERK1/2 phosphorylation, but this rescue was blocked
by silencing MCT1 expression. In addition, disruption of glycol-
ysis via glucose deprivation effectively suppressed the hypoxic
phosphorylation of c-Raf and ERK1/2 as well as NDRG3 expres-
sion, which could be rescued by NDRG3(N66D) (Figure 6H). In
contrast, glutamine deprivation exhibited negligible effects.
These results indicate that hypoxia-induced phosphorylation of
c-Raf and ERK1/2 is dependent on lactate production, mainly
from glycolysis, and NDRG3 functions as an essential mediator
of the lactate-induced activation of Raf-ERK pathway.
Dependence of Lactate-Induced Hypoxic Cell Growth
and Angiogenesis on NDRG3-Mediated ERK1/2 Activity
Finally, we examined the biologic relevance of the NDRG3-medi-
ated activation of the Raf-ERK pathway to lactate-triggered
hypoxia responses. Exogenously provided lactate significantly
compensated for the growth deficit of Huh-1 cells under
mild hypoxia, caused by LDHA silencing (Figure 7A). However,
the lactate-mediated rescue was abrogated by depletion of
NDRG3 or pharmacological blockade of ERK signaling. Similarly,
exogenous lactate restored the hypoxia-induced angiogenic ca-
pacity of LDHA-knockdown Huh-1 cells in tube-forming assays,
whichwas again abolishedbyNDRG3depletion or ERK inhibition
(Figure 7B). In parallel, the hypoxic expression of angiogenic
marker genes, disrupted by LDHA knockdown, was recovered
by exogenous lactate but disrupted again by NDRG3 depletion
or ERK inhibition (Figure S7A). We then examined the relevance
of NDRG3-mediated Raf-ERK pathway activation to the growth
of tumors in vivo. Western blot analysis of the tumors formed
by Huh-1 cells engineered for LDHA and/or NDRG3 expression
in the in vivo tumorigenesis analysis (Figures 4G and S4L)
indicated that phosphorylation of c-Raf and ERK was clearly up-
regulated in tumors expressing NDRG3(N66D) compared to
mock controls (Figures 7C and S7B). Consistently, we observed
a predominant expression of angiogenic marker genes in
NDRG3(N66D)-expressing tumors. These results, together with
those in Figures 4 and 6, demonstrate that lactate plays essential
roles in promoting cell growth and angiogenesis under hypoxia,
depending on the NDRG3-mediated activation of the c-Raf-
ERK1/2 pathway.
We then examined the clinical relevance of NDRG3 expression
and ERK1/2 activity by immunohistochemical analysis of human
hepatocellular carcinoma (HCC). NDRG3 was barely expressed
in the normal liver, while moderate to strong levels were detect-
able in HCC tissues in the cytoplasm and the plasma membrane
(Figure 7D). Among 103 HCC cases examined using antibodies
for NDRG3 and phospho-ERK1/2, 25 cases (24.3%) were
positive for NDRG3 protein expression in a manner that
was significantly associated with ERK1/2 activation (Figure 7D).
In summary, these results indicate that aberrant NDRG3by NDRG3. The p values were assessed by Student’s t test. n = 5/group.
G3. Results are mean ± SD of two experiments. The p values were assessed by
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Figure 5. Lactate Binds to NDRG3 and Blocks Its Ubiquitination by VHL
(A) Effects of lactate on in vitro ubiquitination of NDRG3 by recombinant PHD2/VHL complex immunoprecipitated fromHEK293T cells expressing PHD2-Flag and
VHL-HA.
(B) Molecular interaction between L-lactate and NDRG3 protein in vitro. Results are mean ± SD of three experiments. The p value was assessed by Student’s
t test.
(C) Molecular interaction between L-lactate and a variant NDRG3 protein (N3(G138W)) mutated in the putative L-lactate binding site. Results are mean ± SD of
three experiments. The p value was assessed by Student’s t test.
(D) Interaction profile of NDRG3 protein with PHD2 or VHL in HEK293T cells during the progression of hypoxia. Quantified values for western blot images are
shown on the right. Results are mean ± SD of two experiments. The p value was assessed by Student’s t test.
(legend continued on next page)
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expression is closely associated with tumor development in vivo
as well as the pathological activation of the ERK pathway.
DISCUSSION
Lactate has been regarded as a dead-end product of glycolysis
and glutaminolysis until it recently emerged as an alternative en-
ergy source and an inducer of tumor angiogenesis (Doherty and
Cleveland, 2013). Knockdown of LDHA expression or inhibition
of its activity suppressed tumor cell growth in vitro and in vivo
(Fantin et al., 2006; Le et al., 2010). However, the key elements
and mechanisms of lactate-induced biological responses re-
mained unknown. In this study, we showed the existence of
NDRG3-mediated lactate signaling and its roles in hypoxia re-
sponses. During hypoxia, low oxygen concentrations and
elevated lactate levels highly induced NDRG3 protein expres-
sion, leading to the activation of theRaf-ERKpathway to promote
angiogenesis and hypoxic cell growth. Thus, NDRG3 acts as a
lactate sensor that triggers downstreamkinase signaling in ahyp-
oxia-dependentmanner, and theNDRG3-Raf-ERK axis provides
the genetic basis for the lactate-induced hypoxia responses.
We showed thatNDRG3 expression is genetically independent
of HIFs and rather determined at the protein level by lactate.
Lactate accumulates at the later phase of hypoxia, promoted
by the upregulation of glycolysis and LDHA expression during
the earlier stages of hypoxia where HIF-1a plays a critical role
as a part of metabolic adaptation (Cassavaugh and Lounsbury,
2011). Therefore, the lactate signaling and subsequent bio-
logic responses appear to be functionally coupled to the HIF-
1a-induced metabolic reprogramming, by employing NDRG3
as the critical link. In this regard, it is suggested that portions of
the hypoxia responses, especially those occurring at the later
phase of hypoxia, that have been so far attributed to HIF-1a
might, in fact, be under the direct control of NDRG3-mediated
lactate signaling. The results of gene set enrichment analysis
for the functions of NDRG3 and HIF-1a during hypoxia support
this possibility (Figures 3 and S3). Therefore, our study suggests
that HIF-1a and NDRG3 might form an oxygen-dependent regu-
latory chain for hypoxia responses, which is broadly divided into
two chronological phases (Figure 7E); at the early phase, low O2
levels signal for the accumulation of HIF-1a, which then regulates
the gene expression necessary for early adaptive responses
including metabolic reprogramming, while at the later phase, up-
regulated lactate production signals for the accumulation of
NDRG3, which subsequently activates the Raf-ERK pathway to
induce responses necessary for coping with prolonged hypoxia.
The lactate-NDRG3-Raf-ERK axis of hypoxia signaling sug-
gests that hypoxic lactate production might be an integral part
of normal physiology, playing active roles in promoting angio-
genesis and cell growth under prolonged hypoxia. It stands to
reason that the functional coupling between HIF-1a-induced(E) Interaction of different forms of NDRG3 proteins with PHD2 or VHL in HEK2
western blot images are shown on the right. Results are mean ± SD of three exp
(F) Ubiquitination assay of variant NDRG3 proteins from HEK293T cells grown in
(G) Effects of inhibiting hypoxic lactate production by oxamate on the interaction
values for western blot images are shown on the right. Results are mean ± SD o
See also Figure S5.metabolic reprogramming and NDRG3-mediated lactate sig-
naling ensures that cells facing prolonged hypoxia achieve the
maximal possible growth in a hypoxic environment. This can
be achieved by, first, generating biosynthetic building blocks
and energy via the HIF-1a-mediated upregulation of glycolysis,
and subsequently, by providing cues for cell growth and
angiogenesis via the NDRG3-mediated c-Raf-ERK signaling.
Therefore, NDRG3-mediated lactate signaling may provide a
self-sufficient mechanism for the cells in local tissues to recover
from hypoxia without the need for additional extracellular sig-
nals, for example, during development. Moreover, NDRG3-
mediated signaling provides an extra layer of biological security
for the cells escaping prolonged hypoxia since the NDRG3 pro-
tein, once stabilized by lactate binding, remains quite stable
even when cells are reoxygenated.
Growing evidence suggests that lactate may play active roles
in cancer progression, as it mediates cancer-cell intrinsic effects
on metabolism as an oxidative metabolite and non-cancer-cell
autonomous effects on several cell types in the tumor microen-
vironment (Doherty and Cleveland, 2013). Our results indicate
that glycolysis is the main source of lactate production that
is responsible for the hypoxic induction of NDRG3 protein
expression and Raf-ERK activation. Cancer cells frequently
exhibit an increased dependence on glycolysis, and therefore,
the discovery of the lactate-NDRG3-Raf-ERK axis and its role
in angiogenesis and hypoxic cell growth may provide an impor-
tant explanation for the growth advantage offered by a glycolytic
phenotype to cancers. In this regard, lactate might be consid-
ered an oncometabolite that drives the progression of solid
tumors as an alternative fuel, an agent modulating the tumor
microenvironment, and a signaling molecule.
Many characteristics of hypoxia responses are also exploited
by diseased cells (Cassavaugh and Lounsbury, 2011). The pres-
ence of hypoxia is correlated with poor patient prognosis and
poor treatment outcome in cancers (Jubb et al., 2010; Semenza,
2004), and therefore, hypoxia has been an important target for
cancer therapy. Although HIF is the prime target in this regard,
concerns have been raised that the simple inhibition of HIF
may not be enough to prevent the progression of hypoxia-
induced diseases, since many studies indicated that compensa-
tory, HIF-independent pathways can be induced when a single
factor is inhibited (Mizukami et al., 2005, 2007; Carmeliet et al.,
1998; Rapisarda et al., 2009; see Introduction for supporting ex-
amples). These observations collectively led to the suggestion
that the most successful anti-hypoxia strategy may require a
combination of agents inhibiting HIF-independent as well as
HIF-dependent pathways (Mizukami et al., 2007; Fong, 2008).
Despite the likelihood of functional coupling with HIF-1a,
NDRG3 seems to have distinct functions in hypoxia response
regulation as indicated by gene set enrichment analysis of the
transcriptome data forNDRG3- andHIF1A-depleted cells during93T cells at different oxygen conditions. WT, wild-type. Quantified values for
eriments. The p value was assessed by Student’s t test.
normoxia or under hypoxia.
of different NDRG3 proteins with PHD2 or VHL in HEK293T cells. Quantified
f three experiments. The p value was assessed by Student’s t test.
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Figure 6. NDRG3 Is Required for Hypoxia-Induced Raf-ERK1/2 Activation
(A) Effects of NDRG3 knockdown on hypoxia-induced ERK1/2 activation in SK-Hep-1 cells.
(B) Effects of NDRG3 knockdown on hypoxia-induced RAF activation in SK-Hep-1 cells.
(C) Activation of ERK1/2 and c-Raf by NDRG3 in normoxia in HEK293T cells.
(D) Suppression of the hypoxic phosphorylation of c-Raf and ERK1/2 by NDRG3 knockdown and its rescue by ectopic expression of NDRG3.
(E) In vitro phosphorylation of recombinant c-Raf protein by the NDRG3-containing complex immunoprecipitated from HEK293T cells.
(F) Interaction profile between endogenous NDRG3 and c-Raf proteins during progression of hypoxia. Phosphorylation profiles of c-Raf and ERK are also shown.
(G) Lactate dependence of the NDRG3-mediated c-Raf-ERK activation during hypoxia in Huh-1 cells.
(H) Suppression of the hypoxic phosphorylation of c-Raf and ERK1/2 by glucose deprivation and its rescue by NDRG3 overexpression.
See also Figure S6.hypoxia. Therefore, these observations, along with the roles of
NDRG3 in hypoxia responses as shown in this study, suggest
that combinatorial targeting of HIF and NDRG3 might prove
highly effective in cancer therapy. Abrogation of tumor growth
when NDRG3was depleted in combination with either HIFs sup-
ports the feasibility of this strategy (Figure 3H).606 Cell 161, 595–609, April 23, 2015 ª2015 Elsevier Inc.In conclusion, NDRG3 provides a crucial genetic evidence
for the oxygen-dependent regulation of HIF-independent hypoxia
signaling. The regulation and functionsofNDRG3 in hypoxia imply
that the PHD2/VHL system can control both HIF-dependent
and HIF-independent hypoxia responses in an oxygen-depen-
dent manner. Therefore, the lactate-NDRG3-Raf-ERK signaling
A B
C D
E
Figure 7. Lactate-Induced Cell Growth and Angiogenesis Depend on NDRG3 Expression and ERK1/2 Activity
(A) Dependence of the hypoxic growth of Huh-1 cells on lactate, NDRG3, and ERK1/2 activity.
(B) Dependence of the hypoxia-induced angiogenic activity of Huh-1 cells on lactate, NDRG3, and ERK1/2 activity.
(C) Upregulation of c-Raf-ERK1/2 phosphorylation and pro-angiogenic gene expression in tumor xenografts formed by Huh-1 cells overexpressing NDRG3.
(D) Immunohistochemical analysis of NDRG3 and phospho-ERK1/2 expression in human liver cancers. Relationship between NDRG3 protein and phospho-
ERK1/2 expression was assessed by c2 test.
(E) A scheme outlining the regulatory mechanism for prolonged hypoxia responses involving lactate and NDRG3.
See also Figure S7.
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pathwaymay provide an extendedmechanistic clue to the under-
standingof disorderscausedbymutations inVHL (hemangioblas-
toma, renal cell carcinoma, pheochromocytoma, etc.) (Maher
et al., 2011) or PHD2 (familial erythrocytosis-3) (Percy et al.,
2006) aswell as thehypoxia-relatedphysiological andpathophys-
iological responses (Cassavaugh and Lounsbury, 2011).
EXPERIMENTAL PROCEDURES
Cell Lines
Human cell lines, PLC/PRF/5, SK-HEP-1, MCF-10A, MCF-7, IMR-90, HeLa,
SW480, and HEK293T were purchased from American Type Culture Collec-
tion. Two human hepatoma cell lines, Huh-1 and Huh-7, were obtained from
Japanese Cancer Research Resources Bank. Cells were cultured under stan-
dard conditions (see Extended Experimental Procedures).
Identification of PHD2-Binding Proteins
In order to identify PHD2-binding proteins, we carried out mass spectrometric
analysis of the proteins immunoprecipitated from MCF-7 cells cultured under
hypoxia for 24 hr in the presence of the proteasome inhibitor, MG132. We
avoided the yeast two-hybrid screen as it has known technical limitations for
some types of proteins. A detailed method is described in Extended Experi-
mental Procedures under the subtitle Micro-LC-MS/MS Analysis and Protein
Database Search.
RNA Interference
We used commercial pooled siRNA products (SMARTpool, Dharmacon) for
transient knockdown of NDRG3, NDRG1, HIF-1A, EPAS1 (HIF-2A), ARNT
(HIF-1B), VHL, LDHA,MCT1, andMCT4. Otherwise, siRNAs were synthesized
fromSamchullypharm (Korea). The sequences of siRNAs are listed in Table S1.
Protein Structure Modeling and Docking Simulation
Prediction of NDRG3 protein structure was achieved using Modeler 9v10 (Es-
war et al., 2008). Protein-protein and protein-ligand docking simulations were
performed using the HEX6.3 program (Ritchie and Kemp, 2000) and the Auto-
dock Vina software (http://vina.scripps.edu/index.html), respectively. Detailed
methods are described in Extended Experimental Procedures.
L-Lactate Measurement and Binding Assay
L-Lactate production was measured using the EnzyChrom L-Lactate Assay kit
(BioAssay Systems). The protocol for the analysis of interaction between re-
combinant NDRG3-GST protein and L-[14C]-lactate (PerkinElmer) is described
in Extended Experimental Procedures.
Statistical Analysis
Statistical significance of the data wasmostly assessed by using the Student’s
t test except for the tissue microarray data for which the c2 test was used.
Miscellaneous Methods
Virus-mediated gene expression, immunoprecipitation and western blotting,
RT-PCR, site-directed mutagenesis, expression and purification of recombi-
nant proteins, production of anti-NDRG3 antibody, ubiquitination assays,
gene expression profiling, cell growth assays, apoptosis assay, in vitro kinase
assay, tumorigenesis in a mouse model, in vivo angiogenesis assay, immuno-
fluorescence microscopy, and tissue microarray analysis are described in
Extended Experimental Procedures. Contents dealing with human and animal
subjects were approved by the Institutional Review Board of Inje University
Seoul Paik Hospital (Seoul, Korea) and KRIBB, respectively. Antibodies and
primer sequences used for RT-PCR analyses and site-directed mutagenesis
are listed in Tables S2, S3, and S4.
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